Abstract
Aim: To find out statistical data regarding intravitreal injections in an outpatient department setup at a tertiary center in Oman. Design: Retrospective chart review. Methods: Data collection of patients who underwent intravitreal injections from November 2009 to May 2013 at Sultan Qaboos University Hospital. Results: Throughout a period of 42 months, a total of 711 intravitreal injections were performed. That included 214 patients (275 eyes). Around one-third of the eyes received two injections or more. The injected agents were bevacizumab (59.8%), ranibizumab (32.3%), triamcinolone (7.5%), and very few patients with endophthalmitis received intravitreal antibiotics and antifungal agents. The three most common indications for the injection therapy were diabetic macular edema (50.9%), choroidal neovascularization (24.3%), and retinal vein occlusive diseases (11.5%). Serious adverse events were rare, and they occurred as ocular (0.9% per patient) and systemic (3.3% per patient). There were 42 eyes received intravitreal triamcinolone, and 24% of them developed intraocular hypertension that required only medical treatment. Conclusion: Different intravitreal agents are currently used to treat many ocular diseases. Currently, therapy with intravitreal agents is very popular, and it carries a promising outcome with more efficiency and safety.
| Original language | English |
|---|---|
| Pages (from-to) | 166-170 |
| Number of pages | 5 |
| Journal | Oman Journal of Ophthalmology |
| Volume | 8 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Oct 1 2015 |
Fingerprint
Keywords
- Antivascular endothelial growth factors
- choroidal neovascularization
- diabetic macular edema
- intravitreal
- Oman
- retina
- retinal vascular occlusion
ASJC Scopus subject areas
- Ophthalmology
Cite this
Experience of intravitreal injections in a tertiary Hospital in Oman. / Al-Hinai, Ahmed S.
In: Oman Journal of Ophthalmology, Vol. 8, No. 3, 01.10.2015, p. 166-170.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Experience of intravitreal injections in a tertiary Hospital in Oman
AU - Al-Hinai, Ahmed S.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Aim: To find out statistical data regarding intravitreal injections in an outpatient department setup at a tertiary center in Oman. Design: Retrospective chart review. Methods: Data collection of patients who underwent intravitreal injections from November 2009 to May 2013 at Sultan Qaboos University Hospital. Results: Throughout a period of 42 months, a total of 711 intravitreal injections were performed. That included 214 patients (275 eyes). Around one-third of the eyes received two injections or more. The injected agents were bevacizumab (59.8%), ranibizumab (32.3%), triamcinolone (7.5%), and very few patients with endophthalmitis received intravitreal antibiotics and antifungal agents. The three most common indications for the injection therapy were diabetic macular edema (50.9%), choroidal neovascularization (24.3%), and retinal vein occlusive diseases (11.5%). Serious adverse events were rare, and they occurred as ocular (0.9% per patient) and systemic (3.3% per patient). There were 42 eyes received intravitreal triamcinolone, and 24% of them developed intraocular hypertension that required only medical treatment. Conclusion: Different intravitreal agents are currently used to treat many ocular diseases. Currently, therapy with intravitreal agents is very popular, and it carries a promising outcome with more efficiency and safety.
AB - Aim: To find out statistical data regarding intravitreal injections in an outpatient department setup at a tertiary center in Oman. Design: Retrospective chart review. Methods: Data collection of patients who underwent intravitreal injections from November 2009 to May 2013 at Sultan Qaboos University Hospital. Results: Throughout a period of 42 months, a total of 711 intravitreal injections were performed. That included 214 patients (275 eyes). Around one-third of the eyes received two injections or more. The injected agents were bevacizumab (59.8%), ranibizumab (32.3%), triamcinolone (7.5%), and very few patients with endophthalmitis received intravitreal antibiotics and antifungal agents. The three most common indications for the injection therapy were diabetic macular edema (50.9%), choroidal neovascularization (24.3%), and retinal vein occlusive diseases (11.5%). Serious adverse events were rare, and they occurred as ocular (0.9% per patient) and systemic (3.3% per patient). There were 42 eyes received intravitreal triamcinolone, and 24% of them developed intraocular hypertension that required only medical treatment. Conclusion: Different intravitreal agents are currently used to treat many ocular diseases. Currently, therapy with intravitreal agents is very popular, and it carries a promising outcome with more efficiency and safety.
KW - Antivascular endothelial growth factors
KW - choroidal neovascularization
KW - diabetic macular edema
KW - intravitreal
KW - Oman
KW - retina
KW - retinal vascular occlusion
UR - http://www.scopus.com/inward/record.url?scp=84948777006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84948777006&partnerID=8YFLogxK
U2 - 10.4103/0974-620X.169896
DO - 10.4103/0974-620X.169896
M3 - Article
AN - SCOPUS:84948777006
VL - 8
SP - 166
EP - 170
JO - Oman Journal of Ophthalmology
JF - Oman Journal of Ophthalmology
SN - 0974-620X
IS - 3
ER -